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L. Mazzucchelli, M. Heikenwalder, M.O. Kurrer, 
S. Behnke, J. Frey, A. Oxenius, H. Joller, 
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Locarno, Berne, Switzerland 
Background: HIV is a human-specific virus and con- 
sequently does not infect the conventional labora- 
tory animals such as mice or rats. Available mouse 
models transplanted with either human peripheral 
blood leukocytes (PBL) or human fetal tissues are 
limited in their use for studying HIV infection since 
they show xeno-reactivity (hu-PBL-SCID), low HIV 
replication rates, short infection spans, and biased 
CCRS- or CXCR4-co-receptor tropic strain infection. 
Rag2-/-'yc-/- mice, transplanted as newborns with 
human cord blood CD34+cells, were recently shown 
to develop human B-, T-, and dendritic cells and 
to reconstitute primary and secondary lymphoid 
organs in situ. In this work, we tested these mice 
for sustaining HIV infection. 
Results: CD34 + cell transplanted Rag2-/-~c-/- mice 
with a mean human peripheral blood CD45 + and 
CD4 ÷ cell chimerism of 29.4+18.2% and 2.7+3.0%, 
respectively, were susceptible to either CCR5- or 
CXCR4-tropic strains with up to 2 x 106copies/ml 
2-6 weeks after infection. Thereafter, viremia sta- 
bilized and was maintained at tower levels for 
up to 120 days, the longest time followed. CD4 ÷ 
T-cell depletion occurred at the earliest 100 days 
after detectable viremia when infected with CCR5- 
tropic strains. In contrast, a marked CD4 ÷ T-cell 
depletion was observed in all mice infected with 
CXCR4-tropic strains simultaneously with the initial 
rise of plasma HIV RNA. From 18 up to 120 days 
post-infection, spleens and lymph nodes of mice 
infected with either CCRS- or CXCR4-tropic strains 
contained p24 ÷ cells. In thymi, however, p24 ex- 
pression was detected predominantly following in- 
fection with CXCR4-tropic strain, but only infre- 
quently or not at all in mice infected with CCRS- 
tropic strains, consistent with the expression of 
CXCR4 but not CCR5 on human CD4 ÷ thymocytes. 
Conclusion: Rag2-/-yc-/- mice transplanted with 
human CD34 ÷ cells develop long-term, high-titer, 
and lymphoid organ disseminated infection irre- 
spective of co-receptor selectivity of HIV strain, 
closely resembling HIV infection in man. In partic- 
ular, by using HIV strains with distinct co-receptor 
selectivity, we clearly illustrate the higher cyto- 
pathic potential of CXCR4-tropic strains as com- 
pared to CCRS-tropic strains. This straightforward 
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to generate and cost-effective invivo model should 
be valuable to study virus-induced pathology, and 
to rapidly evaluate new approaches aiming to pre- 
vent or treat HIV infection. 
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E. Dragomir*, C. Selicean, C. Bondor, S. Bocsan, 
C. Itu, C. Jianu. Teaching Hospital o[ In[ectious 
Diseases, Cluj-Napoca, Romania 
Background: Anemia is a frequent complication 
of infection with the human immunodeficiency 
virus (HIV). Several factors are linked to a higher 
rate of anemia in people with HIV: lower CD4 cell 
counts, higher viral toad, taking zidovudine (ZDV), 
being a woman. 
Objective: The purpose of this study was to assess 
the effect of gender, clinical-immunological status, 
CD4 cell count and Anti Retroviral Therapy (ART) on 
the prevalence of anemia in HIV infected adults. 
Methods: We studied 98 patients admitted and 
recorded in Teaching Hospital of Infectious Dis- 
eases from Cluj-Napoca, Romania between Jan- 
uary 1989 and August 2005. Anemia was defined 
as hemoglobin (Hb) less than 12g/dl in women 
and less than 13g/dl in men. Most of the patients 
were followed every four months until death or 
toss to follow-up. We calculated the density rate, 
we estimated if anemia is at higher rate in women 
compared to men (using Z test), at HIV compared 
to AIDS, we made the correlation between CD4 cell 
count and Hb level (Pearson correlation coeffi- 
cient). We also estimated the rate of anemia in 
patients taking ART compared with patients with- 
out ART. Data were computed with SPSS, Excel and 
Epilnfo. 
Results: From 372 records, 183 had anemia. The 
density rate was 62.8 per 100 people. In aver- 
age Hb in women was 12.1±1.78 and in men 
12.7±1.95. Anemia is at higher rate in AIDS 
patients compared to HIV seropositive status, 
OR=18.41 (10.58-32.21), p= 0.0000007. Pearson 
correlation coefficient between Hb and CD4 was 
R=0.254 (p=0.001). From 183 records with ane- 
mia, 117 had ART, 70 including ZDV. Anemia was 
more frequent in patients taking ART (including 
ZDV) compared with patients taking other com- 
binations, OR= 1.69 (1.01-2.83), p=0.032, but is 
more frequent in patients without ART compared 
with patients taking ZDV OR= 2.25 (1.27-4.00) or 
compared with patients taking other combinations 
OR=3. 81 (2.10-6.9) p=0.0000016, (95%1C). 
Conclusion: Anemia is a frequent complication in 
HIV infected patients. Anemia is more frequent in 
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men, (in different study settings is more frequent 
in women). AIDS clinical-immunological status is 
associated with increased risk of anemia. Lower 
CD4 ceil counts are [inked to higher rate of ane- 
mia. The rate of anemia went down when patients 
started using ART. However, ART has not eliminated 
anemia; there was an increased rate in patients 
whose ART regimen contained ZDV. 
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Hospital Zurich, Switzerland, 2National Reference 
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Background: HIV-1/HIV-2 co-infection is infre- 
quently encountered. It was suggested that HIV-2 
has a protective effect with regards to subsequent 
HIV-1 superinfection. 
Objective: To describe a we[[ documented case of 
HIV-1 superinfection in a previously HIV-2 mono- 
infected woman. 
Methods: Diagnostic assays used: HIV-1 and -2- 
specific antibodies: ELISA (screening), Western blot 
analysis (Gene[abs Diagnostics), or line immuno- 
assay (INNOLIA, Innogenetics). HIV-1-RNA: COBAS 
Amp[icor H IV Monitor assay. Retrospective analyses 
of HIV-1 -RNA in plasma or provira[ DNA in PBMC: in- 
house real-time PCR with primers in gag and poL 
HIV-2-RNA or-DNA RT-PCR: PCR with primers in LTR 
and gag. RT-activity: u[trasensitive PERT assay. 
Results (case report): In 12/01 a 1962 born woman 
from Benin presented with preterm contractions. 
HIV-1 and -2 screening tests were both reactive. 
Western blot revealed a positive result for HIV-2 
but a negative one for HIV-1. HIV-1 and HIV-2 
plasma RNA were undetectab[e. In 1/02 assays 
were repeated and confirmed. Baseline CD4 count 
was 729 ceils/u[ (48%). The child was born by cae- 
sarean section in 12/01 in the absence of antiretro- 
viral treatment but remained HIV negative. In 5/02 
CD4 count suddenly dropped to 340 (26%). Now, 
HIV-1 plasma RNA was detectable (540copies/m[) 
and Western blot for HIV-1 was unambiguously 
positive. HIV-RNA increased to 1760copies/m[ in 
10/02 and spontaneously dropped to 63copies/m[ 
in 1/05. CD4 count rose to 578 (27%). No HIV associ- 
ated disease developed. HIV-1 provira[ DNA amplifi- 
cations for gag and po[ were positive. Phy[ogenetic 
analysis revealed most likely a subtype A virus. 
HIV-2 plasma RNA and provira[ DNA remained unde- 
tectab[e despite different attempts using different 
primer pairs. In summary, HIV-I seroconversion be- 
tween 1102 and 5102 was clearly demonstrated by 
newly emerging antibodies against TM and SU env 
antigens of HIV-I in the INNOLIA assay. 
Conclusion: Here, we demonstrate a rare case of 
a chronically HIV-2 infected individual who was 
superinfected by HIV-I. The benign course of the 
HIV-I infection with almost undetectab[e HIV-I 
RNA in the absence of antiretrovira[ treatment may 
be the consequence of a potential immunoprotec- 
tive effect induced by HIV-2 against HIV-I or by 
virat interference at the co-receptor [eve[. 
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Seminal Fluid Variably Influences HIV-1 Infection 
of Lymphocytes, Macrophages and Dendritic 
Cells 
M. Moriuchi, H. Moriuchi*. Nagasaki University 
Graduate School oJ: Biomedical Sciences, Japan 
Background: Sexual transmission of human immun- 
odeficiency virus type 1 (HIV-1) is not very ef- 
ficient (approximately 0.1% per coitus), although 
frequent exposure to genital secretions such as 
semen ultimately leads to successful transmission 
of HIV-1 that is almost exclusively R5 (macrophage- 
tropic) phenotype. Semen contains macrophages 
and [ymphocytes, and dendritic ceils are consid- 
ered to be the first target of HIV-1 in the recessive 
genital/rectal mucosa. 
Objectives: To explore seminal fluid effects on 
HIV-1 infection of [ymphocytes, monocyte-derived 
macrophages (MDM) or monocyte-derived endritic 
ceils (MDDC) in vitro. 
Methods: HIV-1 infection of the respective ceils 
was investigated by single- or multiple-round viral 
replication assays in the presence or absence of 
seminal fluid. Effects of seminal fluid on cytotoxi- 
city, ceil surface expression of CCRS, and activity 
of HIV-1 long terminal repeat (LTR) promoter were 
assessed by MTT assays, flow cytometry and tran- 
sient expression assays, respectively. HIV-1 neu- 
tralization assays were performed by inoculating 
HIV-1 stocks pretreated with seminal fluid onto 
MAGIC5 ceil mono[ayer. HIV-1 transmission assays 
were performed by pulsing AZT-treated MDDC by 
HIV-1 in the presence or absence of seminal fluid, 
cocu[turing them with [ymphocytes, and quantitat- 
ing provira[ DNA by real time PCR. 
Results: Seminal fluid was toxic to [ymphocytes and 
inhibited HIV-1 infection of activated [ymphocytes. 
On the other hand, seminal fluid rather supported 
MDM cultures and had dichotomous effects on HIV-1 
infection of MDM: it inhibited an early step of HIV-1 
